New Drug Could Transform Pancreatic Cancer Treatment By: Benzinga via Benzinga May 18, 2015 at 14:16 PM EDT Halozyme Therapeutics, Inc. (NASDAQ: HALO) has developed a new drug called PEGPH 20, which is changing the way pancreatic cancer ... Read More >> Related Stocks: Halozyme Therapeutic